EA-230, a powerful and precise inhibitor, finds its application in the biomedical realm for efficacious intervention against a myriad of cancer types, encompassing lung, breast, and colorectal cancer. Employing a mechanism targeting distinct protein kinases implicated in the proliferation of tumors and the formation of blood vessels, this compound exhibits remarkable potential.
CAT No: R2054
CAS No:503844-09-5
Chemical Name:(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-methylbutanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.